Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03827876
Recruitment Status : Recruiting
First Posted : February 4, 2019
Last Update Posted : February 4, 2019
Sponsor:
Collaborator:
LEO Pharma
Information provided by (Responsible Party):
Psoriasis Treatment Center of Central New Jersey

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : September 15, 2019
  Estimated Study Completion Date : December 15, 2019